Trial Profile
Imaging [18F]AV-1451 and [18F]AV-45 in Acute and Chronic Traumatic Brain Injury
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary) ; Flortaucipir-F-18 (Primary)
- Indications Mild cognitive impairment; Traumatic brain injuries
- Focus Diagnostic use
- 30 Apr 2019 Status changed from active, no longer recruiting to completed.
- 02 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
- 02 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Feb 2018.